We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$757M
AUM Growth
+$293M
Cap. Flow
+$210M
Cap. Flow %
27.7%
Top 10 Hldgs %
37.11%
Holding
384
New
211
Increased
9
Reduced
13
Closed
104

Sector Composition

Rank Sector Weight
1 Healthcare 30.35%
2 Financials 10.57%
3 Consumer Discretionary 9%
4 Technology 5.91%
5 Industrials 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETAC
101
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$2.05M 0.27%
200,000
-299,995
-60% -$2.95M
GOAC
102
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
$2.04M 0.27%
200,000
-199,996
-50% -$1.97M
FVAM
103
DELISTED
5:01 Acquisition Corp
FVAM
$2.03M 0.27%
+200,000
New +$2.02M
GLS
104
DELISTED
Gelesis Holdings, Inc.
GLS
$2.03M 0.27%
199,998
PTK
105
DELISTED
PTK Acquisition Corp.
PTK
$2.03M 0.27%
200,000
-40,000
-17% -$395K
YAC
106
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$2.02M 0.27%
+199,995
New +$1.98M
KSMT
107
DELISTED
Kismet Acquisition One Corp Ordinary Shares
KSMT
$2.02M 0.27%
+200,000
New +$1.96M
BSN
108
DELISTED
Broadstone Acquisition Corp.
BSN
$2.01M 0.27%
+199,998
New +$1.96M
HPX
109
DELISTED
HPX Corp.
HPX
$2M 0.26%
199,998
NHIC
110
DELISTED
NewHold Investment Corp. Class A Common Stock
NHIC
$2M 0.26%
200,000
-74,998
-27% -$737K
BNR
111
Burning Rock Biotech
BNR
$115M
$1.85M 0.24%
+8,000
New +$2.15M
CMAX
112
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.84M 0.24%
+3,940
New +$1.32M
ASAQ
113
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$1.81M 0.24%
+180,000
New +$1.76M
ADPT icon
114
Adaptive Biotechnologies
ADPT
$4.05B
$1.77M 0.23%
+30,000
New +$1.55M
FMTX
115
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1.75M 0.23%
+50,000
New +$2.18M
CSTL icon
116
Castle Biosciences
CSTL
$988M
$1.68M 0.22%
+25,000
New +$1.36M
RSVAU
117
DELISTED
Rodgers Silicon Valley Acquisition Corp. Unit
RSVAU
$1.67M 0.22%
+125,000
New +$1.53M
ALTUU
118
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$1.66M 0.22%
+160,000
New +$1.65M
MREO
119
Mereo BioPharma
MREO
$43.5M
$1.65M 0.22%
+461,639
New +$1.16M
STRO icon
120
Sutro Biopharma
STRO
$423M
$1.63M 0.21%
+7,500
New +$1.24M
SPRQ.U
121
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
$1.62M 0.21%
+150,000
New +$1.59M
EVGO icon
122
EVgo
EVGO
$224M
$1.61M 0.21%
+149,998
New +$1.55M
GHVIU
123
DELISTED
Gores Holdings VI, Inc. Unit
GHVIU
$1.59M 0.21%
+150,000
New +$1.59M
FCAC
124
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
$1.58M 0.21%
+149,994
New +$1.56M
TWCT
125
DELISTED
TWC Tech Holdings II Corp. Class A Common Stock
TWCT
$1.58M 0.21%
+149,997
New +$1.51M

Similar funds

Monashee Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Monashee Investment Management held 384 positions worth $757M, up 63% from $464M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management deployed $210M of net new capital in Q4 2020, opening 211 new positions and adding to 9 existing holdings. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $38.1M trimmed.

  • Monashee Investment Management's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.
  • Monashee Investment Management added most to Quanterix in Q4 2020, an estimated $8.95M increase.
  • Monashee Investment Management's biggest Q4 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $38.1M.
  • Monashee Investment Management fully exited Caesars Entertainment in Q4 2020, selling an estimated $18.8M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $757M portfolio in Q4 2020.
  • Monashee Investment Management opened 211 new positions and closed 104 in Q4 2020.
  • Monashee Investment Management's portfolio value rose 63% quarter-over-quarter to $757M.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.